List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 441 studies with search of: Epoetin alfa OR Epogen, Procrit[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Epoetin Alfa for HIV-Associated Neuropathy Trial
Conditions: HIV Infections;   Neuropathy
Intervention: Drug: epoetin alfa
2 Completed An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT® (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)
Conditions: Anemia;   HIV Infections
Intervention: Drug: Epoetin alfa
3 Terminated A Study to Assess the Effectiveness of PROCRIT® (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-Infected Patients
Conditions: Anemia;   HIV
Intervention: Drug: epoetin alfa
4 Completed A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy
Conditions: Acquired Immunodeficiency Syndrome;   Anemia
Intervention: Drug: epoetin alfa
5 Completed A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease
Conditions: Anemia;   Acquired Immunodeficiency Syndrome
Intervention: Drug: epoetin alfa
6 Completed A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy
Conditions: Acquired Immunodeficiency Syndrome;   Anemia
Intervention: Drug: epoetin alfa
7 Completed A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease
Conditions: Anemia;   Acquired Immunodeficiency Syndrome
Intervention: Drug: epoetin alfa
8 Completed A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex
Conditions: HIV Infections;   Cytopenias
Interventions: Drug: Filgrastim;   Drug: Epoetin alfa;   Drug: Zidovudine
9 Completed An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)
Condition: HIV Infections
Interventions: Drug: Filgrastim;   Drug: Epoetin alfa;   Drug: Zidovudine
10 Completed Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV
Condition: HIV Infections
Interventions: Drug: Peginterferon alfa-2a, Ribavirin, epoetin-β;   Drug: Peginterferon alfa-2a + Ribavirin for 12 weeks
11 Terminated Treating Patients With Aneurysmal SubArachnoid Hemorrhage (SAH) With Epoetin Alfa
Condition: Subarachnoid Hemorrhage
Interventions: Drug: Epoetin alfa;   Drug: Saline
12 Completed Early and Standard Intervention With 120,000 Units of PROCRIT (Epoetin Alfa) Every Three Weeks in Patients Receiving Chemotherapy
Condition: Anemia
Intervention: Drug: PROCRIT (Epoetin alfa)
13 Completed Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis
Condition: Nephrology
Interventions: Drug: Epoetin alfa RB;   Drug: Epoetin alfa DT
14 Completed A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.
Conditions: Renal Failure , Chronic;   Anemia
Intervention: Drug: epoetin alfa
15 Completed An Efficacy and Safety Study of PROCRIT® (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks
Conditions: Anemia;   Chemotherapy;   Cancer;   Epoetin Alfa
Intervention: Drug: Epoetin alfa
16 Completed Pharmacokinetic/ Pharmacodynamic Study of Epoetin Alfa (PROCRIT®) in Critically Ill Patients.
Conditions: Anemia;   Critical Illness
Intervention: Drug: epoetin alfa
17 Completed Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia
Conditions: Advanced Lung Cancer;   Chemotherapy Induced Anemia
Intervention: Drug: Epoetin Alfa plus Iron
18 Recruiting A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS
Conditions: Acute Myelogenous Leukemia;   Myelodysplastic Syndrome;   Leukemia
Intervention: Drug: Procrit
19 Completed A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease
Conditions: Anemia;   Chronic Kidney Disease
Intervention: Drug: epoetin alfa
20 Completed Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT®) in the Treatment of Anemia.
Conditions: Kidney Diseases;   Anemia
Intervention: Drug: epoetin alfa

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services